Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $102.78 | 2 | 41.9% |
| Consulting Fee | $100.00 | 1 | 40.8% |
| Education | $42.46 | 3 | 17.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $100.00 | 1 | $0 (2017) |
| ImmunoGen, Inc. | $86.62 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $18.09 | 1 | $0 (2024) |
| Novocure Inc. | $16.16 | 1 | $0 (2021) |
| Karyopharm Therapeutics Inc. | $12.45 | 1 | $0 (2020) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.71 | 2 | ImmunoGen, Inc. ($86.62) |
| 2021 | $28.08 | 2 | Novocure Inc. ($16.16) |
| 2020 | $12.45 | 1 | Karyopharm Therapeutics Inc. ($12.45) |
| 2017 | $100.00 | 1 | COMSORT, Inc ($100.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2024 | ImmunoGen, Inc. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $86.62 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/17/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 05/12/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 501 | 999 | $284,091 | $65,317 |
| 2022 | 5 | 465 | 869 | $241,325 | $55,426 |
| 2021 | 5 | 458 | 853 | $202,915 | $54,418 |
| 2020 | 8 | 630 | 1,113 | $267,668 | $65,010 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 129 | 403 | $105,346 | $28,369 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 172 | $70,416 | $12,835 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 125 | 196 | $36,036 | $8,614 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 136 | $37,672 | $6,174 | 16.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 23 | 23 | $10,260 | $3,191 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 32 | $5,600 | $2,029 | 36.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $9,793 | $1,569 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $4,781 | $1,472 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 12 | $4,187 | $1,063 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 94 | 280 | $71,051 | $19,784 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 159 | $63,057 | $12,267 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 119 | 188 | $33,220 | $8,245 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 169 | $45,383 | $7,948 | 17.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 23 | 23 | $10,051 | $3,275 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $6,434 | $2,061 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $10,446 | $1,523 | 14.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 15 | 16 | $1,683 | $323.23 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 73 | 220 | $48,180 | $15,971 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 171 | $56,789 | $12,439 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 128 | 205 | $30,545 | $10,187 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 190 | $43,241 | $9,525 | 22.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 15 | 15 | $6,225 | $2,275 | 36.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 18 | 18 | $5,976 | $1,836 | 30.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $9,313 | $1,775 | 19.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 18 | $2,646 | $410.20 | 15.5% |
About Dr. Meredith Selleck, MD
Dr. Meredith Selleck, MD is a Hematology & Oncology healthcare provider based in Concord, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417908211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meredith Selleck, MD has received a total of $245.24 in payments from pharmaceutical and medical device companies, with $104.71 received in 2024. These payments were reported across 6 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($102.78).
As a Medicare-enrolled provider, Selleck has provided services to 2,054 Medicare beneficiaries, totaling 3,834 services with total Medicare billing of $240,172. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Concord, NH
- Active Since 05/15/2006
- Last Updated 10/29/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1417908211
Products in Payments
- KEYTRUDA (Biological) $100.00
- ELAHERE (Drug) $86.62
- WELIREG (Drug) $18.09
- Optune (Device) $16.16
- XPOVIO (Drug) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Concord
Dr. Sudhathi Chichili, M.d, M.D
Hematology & Oncology — Payments: $21,182
Dr. Walailuk Chaiyarat, Md, MD
Hematology & Oncology — Payments: $19,417
Dr. Elizabeth Odumakinde, M.d, M.D
Hematology & Oncology — Payments: $17,590
Dr. Lesley Martin, M.d, M.D
Hematology & Oncology — Payments: $7,915
Jeanna Walsh, Md, MD
Hematology & Oncology — Payments: $3,449
Meghan Steiner, Md, MD
Hematology & Oncology — Payments: $1,234